Not logged in
  • Log in
    Membership (40243+) Group hosting [?] Wiki
    Franklin Award

    About bioinformatics
    Bioinformatics training
    Bioinformatics jobs

    All information groups
    Online databases Online analysis tools Online education tools More tools

    All software groups
    FTP repository
    SVN & CVS repositories [?]
    Mailing lists

    News & Commentary
  • Submit
  • Archives
  • Subscribe

  • Jobs Forum
    (Career Center)
  • Submit
  • Archives
  • Subscribe
  • News & Commentary - Message forums

    At Work: Forbes: Illumina adds IBM Watson to DNA test for cancer patients
    Submitted by J.W. Bizzaro; posted on Wednesday, January 11, 2017



    Illumina and IBM announced that they would be bundling IBM's Watson Genomics product with Illumina's TruSight Tumor 170, a tool used to help match very sick cancer patients with drugs that might help them.

    The move is the latest effort by DNA sequencing companies to try to get doctors outside major cancer centers like Memorial Sloan-Kettering Cancer Center in New York or M.D. Anderson Cancer Center in Houston to try to scan patients' DNA. The idea is that the DNA test results can be used to help patients who don't have any options find medicines – either approved or experimental – that might help them. So far, this is considered standard practice for late-stage non-small cell lung cancer, but not for cancers in general.

    Expanded view | Monitor forum | Save place

    Start a new thread:
    You have to be logged in to post a reply.


    Copyright © 2018 · Scilico, LLC